Analysts Anticipate Surgery Partners Inc (NASDAQ:SGRY) Will Post Quarterly Sales of $451.34 Million

Brokerages expect Surgery Partners Inc (NASDAQ:SGRY) to report sales of $451.34 million for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Surgery Partners’ earnings. The highest sales estimate is $458.28 million and the lowest is $445.40 million. Surgery Partners reported sales of $443.93 million in the same quarter last year, which would suggest a positive year over year growth rate of 1.7%. The business is expected to report its next quarterly earnings report on Wednesday, November 6th.

On average, analysts expect that Surgery Partners will report full-year sales of $1.82 billion for the current fiscal year, with estimates ranging from $1.81 billion to $1.83 billion. For the next year, analysts anticipate that the company will report sales of $1.92 billion, with estimates ranging from $1.90 billion to $1.95 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Surgery Partners.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.35) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.22) by ($0.13). The business had revenue of $445.40 million during the quarter, compared to analyst estimates of $450.89 million. Surgery Partners had a negative return on equity of 4.65% and a negative net margin of 11.61%. The company’s quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.57) EPS.

Several equities analysts recently weighed in on SGRY shares. ValuEngine upgraded shares of Surgery Partners from a “sell” rating to a “hold” rating in a report on Thursday, August 1st. BidaskClub upgraded shares of Surgery Partners from a “sell” rating to a “hold” rating in a report on Thursday. Finally, Zacks Investment Research lowered shares of Surgery Partners from a “hold” rating to a “sell” rating in a report on Saturday, August 3rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. The company has an average rating of “Hold” and an average target price of $14.33.

In related news, COO Jason Eric Evans acquired 25,000 shares of the stock in a transaction dated Tuesday, August 20th. The stock was bought at an average price of $5.95 per share, with a total value of $148,750.00. Following the completion of the transaction, the chief operating officer now directly owns 111,655 shares of the company’s stock, valued at $664,347.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.30% of the stock is owned by corporate insiders.

Hedge funds have recently modified their holdings of the company. Royal Bank of Canada grew its position in Surgery Partners by 64.3% in the second quarter. Royal Bank of Canada now owns 5,750 shares of the company’s stock valued at $47,000 after purchasing an additional 2,250 shares in the last quarter. Citadel Advisors LLC raised its stake in Surgery Partners by 17.4% in the 2nd quarter. Citadel Advisors LLC now owns 544,948 shares of the company’s stock worth $4,436,000 after purchasing an additional 80,775 shares in the last quarter. Jefferies Group LLC raised its stake in Surgery Partners by 22.4% in the 2nd quarter. Jefferies Group LLC now owns 19,071 shares of the company’s stock worth $155,000 after purchasing an additional 3,490 shares in the last quarter. Marshall Wace LLP bought a new position in Surgery Partners in the 2nd quarter valued at about $1,001,000. Finally, Vanguard Group Inc. increased its holdings in Surgery Partners by 13.0% in the 2nd quarter. Vanguard Group Inc. now owns 1,757,150 shares of the company’s stock valued at $14,303,000 after buying an additional 202,617 shares during the period. 96.32% of the stock is owned by institutional investors.

Surgery Partners stock traded down $0.79 during mid-day trading on Friday, hitting $8.10. The company’s stock had a trading volume of 479,300 shares, compared to its average volume of 322,875. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 2.29. The stock has a market capitalization of $439.88 million, a P/E ratio of -3.31 and a beta of 2.32. Surgery Partners has a twelve month low of $5.38 and a twelve month high of $17.25. The stock’s fifty day moving average price is $6.62 and its two-hundred day moving average price is $9.32.

Surgery Partners Company Profile

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

See Also: Is the QQQ ETF safe?

Get a free copy of the Zacks research report on Surgery Partners (SGRY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.